4//SEC Filing
Glenn Jeffrey S 4
Accession 0001140361-22-047070
CIK 0001305253other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:31 PM ET
Size
7.1 KB
Accession
0001140361-22-047070
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2022-12-22$1.28/sh+100,000$127,950→ 182,355 total
Holdings
- 5,000(indirect: By Spouse)
Common Stock
- 151,064(indirect: By Eiger Group International, Inc.)
Common Stock
- 460(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670382
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:31 PM ET
- Size
- 7.1 KB